FSCN1 and head and neck cancer: Furthermore, in cancer patients with PIK3CA alterations, FSCN1 was downregulated in patients who had a complete response to radiotherapy (cervical cancer, P = 0.057; head and neck cancer, P = 0.037, Figure 1G).